Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Clinical trial NCT01227512 · TERMINATED
Trial details
- NCT number
- NCT01227512
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-05-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.